Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples